Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Diabetes
How do you titrate the dose of an ACE inhibitor in a patient with type 1 diabetes mellitus who is normotensive but has moderately increased albuminuria?
Related Questions
Would you start once-weekly tirzepatide over once daily basal insulin in a patient with Type 2 diabetes with inadequate control on oral antihyperglycemia drugs?
How do you counsel patients on the use of berberine to prevent the progression of prediabetes to type 2 diabetes mellitus?
Besides treadmill, what other exercises may be considered for post-exercise ABIs, and are their diagnostic parameters identical to standard post-exercise ABIs?
Should we be more cautious with the use of GLP 1 R agonist therapy in patients with Type 1 diabetes mellitus and obesity given the increased risk of cardiovascular disease with high body weight variability?
What are the treatment options for severe recurrent hypoglycemia in a patient with malignant insulinoma?
Would you recommend the 1-hour OGTT over the 2-hour OGTT for postpartum glucose tolerance testing in women with previous gestational diabetes?
How do the results of the ESPRIT trial, which evaluated the impact of an SBP target of <120 mmHg on preventing major cardiovascular events, influence your blood pressure management goals for hypertensive patients with diabetes or a history of stroke?
Is it safe to use acarbose in patients with advanced chronic kidney disease?
Do you routinely monitor INR when starting GLP1 R agonist therapy on patients taking warfarin?
What is the recommended frequency and duration of exercise sessions in order to sustain the beneficial effects of exercise on insulin sensitivity?
